Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 1,451 adverse event reports in the FDA FAERS database where BIMEKIZUMAB was used for Psoriasis.

Most Reported Side Effects for BIMEKIZUMAB

Side Effect Reports % Deaths Hosp.
Psoriatic arthropathy 615 25.0% 1 27
Psoriasis 400 16.3% 1 97
Drug ineffective 293 11.9% 1 42
Inappropriate schedule of product administration 238 9.7% 4 56
Injection site pain 225 9.2% 0 38
Product dose omission issue 163 6.6% 0 40
Off label use 160 6.5% 1 36
Oral candidiasis 146 5.9% 0 18
Fatigue 138 5.6% 0 23
Therapy interrupted 138 5.6% 1 31
Pneumonia 118 4.8% 1 37
Incorrect dose administered 115 4.7% 0 19
Hidradenitis 108 4.4% 1 36
Headache 104 4.2% 0 21
Ankylosing spondylitis 94 3.8% 0 1

Other Indications for BIMEKIZUMAB

Psoriatic arthropathy (612) Hidradenitis (238) Product used for unknown indication (213) Ankylosing spondylitis (140) Off label use (61) Axial spondyloarthritis (43) Rheumatoid arthritis (18) Pustular psoriasis (5)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

BIMEKIZUMAB Full Profile All Psoriasis Drugs BIMEKIZUMAB Demographics BIMEKIZUMAB Timeline